Koninklijke DSM N.V.
KDSKF
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.4B
Close$
$60.04
137.3% upside
Current Fair Value
137.3% upsideUndervalued by 137.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.40 Billion |
|---|---|
| Enterprise Value | $5.74 Billion |
| Dividend Yield | $- (0.82%) |
| Earnings per Share | $13.41 |
| Beta | 0.72 |
| Outstanding Shares | 171,536,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 41.69 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 0.4 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0.71 |
| Debt to Equity | 0.38 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Koninklijke DSM NV
CEO: Dimitri de Vreeze / Géraldine Matchett Koninklijke DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, and Innovation Center. The Nutrition segm...